Roles of peroxisome proliferator-activated receptor γ in cardiovascular disease
- 28 February 2002
- journal article
- review article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 16 (1) , 108-114
- https://doi.org/10.1016/s1056-8727(01)00203-3
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Peroxisome Proliferator-activated Receptor-γ Activation Inhibits Interleukin-1β-mediated Platelet-derived Growth Factor-α Receptor Gene Expression via CCAAT/Enhancer-binding Protein-δ in Vascular Smooth Muscle CellsPublished by Elsevier ,2001
- Control of Vascular Cell Proliferation and Migration by PPAR-γDiabetes Care, 2001
- Peroxisome Proliferator-activated Receptor γ-mediated Transcriptional Up-regulation of the Hepatocyte Growth Factor Gene Promoter via a Novel Composite cis-Acting ElementJournal of Biological Chemistry, 2001
- Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by PioglitazoneBiochemical and Biophysical Research Communications, 2000
- Feedback Control of Cyclooxygenase-2 Expression through PPARγJournal of Biological Chemistry, 2000
- Expression of Peroxisome Proliferator-Activated Receptor γ (PPARγ) in Rat Aortic Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1998
- The Antidiabetic Agent Thiazolidinedione Stimulates the Interaction between PPARγ and CBPBiochemical and Biophysical Research Communications, 1997
- Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγScience, 1996
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990